Track Epigral Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Epigral Limited EPIGRAL.NS · Stock Open Epigral Limited in new tab

920.20 INR
P/E
14.01
EPS
62.69
Yield
0.55%
Safety Score
76
P/B
1.71
ROE
16.09
Beta
0.31
Target Price
1728.00 INR
Loading chart...
Key Metrics
Earnings dateNov. 5, 2026
P/E14.01
EPS62.69
Book Value514.92
Price to Book1.71
Debt/Equity25.75
% Insiders68.857%
Growth
Revenue Growth0.16%
Earnings Growth-0.38%
Estimates
Forward P/E8.61
Forward EPS101.95
Target Mean Price1728.00
Dividend
Dividend Yield0.55%
Annual dividends5.00 INR
Ex-Div. DateJune 1, 2026
Payout6.43%

DCF valuation

Model fair value for Epigral Limited (EPIGRAL.NS)
Result
Sign in to run the valuation for EPIGRAL.NS.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
2 analysts · consensus None · mean target 1728.00 INR (low 1456.00, high 2000.00) · as of 30 Oct 2026
Low 1456.00
Mean 1728.00
High 2000.00
Price 920.20
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Epigral Limited Logo Epigral Limited Analysis (EPIGRAL.NS)

India Basic Materials Official Website Stock

Is Epigral Limited a good investment? Epigral Limited (EPIGRAL.NS) is currently trading at 920.20 INR. Market analysts have a consensus price target of 1728.00 INR. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 14.01. This relatively low multiple may signal that Epigral Limited is undervalued compared to historical market norms.

Earnings Schedule: Epigral Limited is expected to release its next earnings report on Nov. 5, 2026. The market consensus estimate for Forward EPS is 101.95.

For income investors, Epigral Limited pays a dividend yield of 0.55%. With a payout ratio of 6%, the dividend appears sustainable.

Investor FAQ

Does Epigral Limited pay a dividend?

Yes, it pays an annual dividend of 5.00 INR (0.55% yield).

What asset class is Epigral Limited?

Epigral Limited is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of 62.69.

Company Profile

Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.

Trades
Dividend Yield
0.55%
Annual Dividends
5.00INR
Next Ex. Div Date
June 1, 2026
Payout Ratio
6.43%
Dividend History paid per year (INR)
Historical Dividends
Year Total Dividends
▸2027
5.00 INR
July 8, 2027 (estimated) 5.0000
▸2026
5.00 INR
July 8, 2026 5.0000
▸2025
6.00 INR
July 11, 2025 3.5000
Feb. 20, 2025 2.5000
▸2024
5.00 INR
Aug. 8, 2024 5.0000
▸2023
5.00 INR
June 27, 2023 2.5000
Feb. 8, 2023 2.5000
Upcoming Dividends
Name Payment Date Status Amount
Epigral Limited Jul 08, 2026 5.0 INR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion